Section 5119.19 | Psychotropic drug reimbursement program.
(A)(1) As used in this section, "psychotropic drug" means, except as provided in division (A)(2) of this section, a drug that has the capability of changing or controlling mental functioning or behavior through direct pharmacological action. "Psychotropic drug" includes all of the following:
(a) Antipsychotic medications;
(b) Antidepressant medications;
(c) Anti-anxiety medications;
(d) Mood stabilizing medications.
(2) "Psychotropic drug" excludes a stimulant prescribed for the treatment of attention deficit hyperactivity disorder.
(B) There is hereby created the psychotropic drug reimbursement program. The program shall be administered by the department of mental health and addiction services.
The purpose of the program is to provide state reimbursement to counties for the cost of psychotropic drugs that are dispensed to inmates of county jails in this state. The department, based on factors it considers appropriate, shall allocate an amount to each county for reimbursement of such psychotropic drug costs incurred by the county.
(C) The director of mental health and addiction services may adopt rules as necessary to implement this section. The rules, if adopted, shall be adopted in accordance with Chapter 119. of the Revised Code.
Available Versions of this Section
- September 29, 2017 – Enacted by House Bill 49 - 132nd General Assembly [ View September 29, 2017 Version ]
- October 17, 2019 – Amended by House Bill 166 - 133rd General Assembly [ View October 17, 2019 Version ]
- October 3, 2023 – Amended by House Bill 33 - 135th General Assembly [ View October 3, 2023 Version ]